P07101 (TY3H_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 143.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Tyrosine 3-monooxygenase EC=1.14.16.2 Alternative name(s): Tyrosine 3-hydroxylase Short name=TH | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 528 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Plays an important role in the physiology of adrenergic neurons. |
| Catalytic activity | L-tyrosine + tetrahydrobiopterin + O2 = 3,4-dihydroxy-L-phenylalanine + 4a-hydroxytetrahydrobiopterin. |
| Cofactor | Fe2+ ion. |
| Enzyme regulation | Phosphorylation leads to an increase in the catalytic activity. |
| Pathway | Catecholamine biosynthesis; dopamine biosynthesis; dopamine from L-tyrosine: step 1/2. |
| Tissue specificity | Mainly expressed in the brain and adrenal glands. |
| Involvement in disease | Defects in TH are the cause of Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]. A form of DOPA-responsive dystonia presenting in infancy or early childhood. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. Some cases present with parkinsonian symptoms in infancy. Unlike all other forms of dystonia, it is an eminently treatable condition, due to a favorable response to L-DOPA. Note=May play a role in the pathogenesis of Parkinson disease (PD). A genome-wide copy number variation analysis has identified a 34 kilobase deletion over the TH gene in a PD patient but not in any controls. Ref.10 |
| Sequence similarities | Belongs to the biopterin-dependent aromatic amino acid hydroxylase family. |
Ontologies
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 3 (identifier: P07101-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 1 (identifier: P07101-2) The sequence of this isoform differs from the canonical sequence as follows: 31-34: Missing. | ||||||
| Isoform 2 (identifier: P07101-3) The sequence of this isoform differs from the canonical sequence as follows: 31-61: Missing. | ||||||
| Isoform 4 (identifier: P07101-4) The sequence of this isoform differs from the canonical sequence as follows: 1-33: Missing. 34-34: Q → M |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 2 – 528 | 527 | Tyrosine 3-monooxygenase | PRO_0000205561 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 85 – 90 | 6 | Poly-Ala | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 361 | 1 | Iron By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 366 | 1 | Iron By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 406 | 1 | Iron By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 19 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 62 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 71 | 1 | Phosphoserine; by PKA By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 33 | 33 | Missing in isoform 4. | VSP_000541 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 31 – 61 | 31 | Missing in isoform 2. | VSP_000544 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 31 – 34 | 4 | Missing in isoform 1. | VSP_000543 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 34 | 1 | Q → M in isoform 4. | VSP_000542 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 112 | 1 | V → M Common polymorphism. Ref.12 Ref.15 Ref.18 Corresponds to variant rs6356 [ dbSNP | Ensembl ]. | VAR_014025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 233 | 1 | R → H in ARSEGS. | VAR_014026 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 236 | 1 | L → P in ARSEGS; severe parkinsonian symptoms in early infancy; strongly reduced stability and catalytic activity; rare mutation. | VAR_014027 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 276 | 1 | T → P in ARSEGS; parkinsonian symptoms in infancy. Corresponds to variant rs28934581 [ dbSNP | Ensembl ]. | VAR_014028 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 314 | 1 | T → M in ARSEGS; parkinsonian symptoms in infancy. | VAR_014029 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 337 | 1 | R → H in ARSEGS; parkinsonian symptoms in infancy. Corresponds to variant rs28934580 [ dbSNP | Ensembl ]. | VAR_014030 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 412 | 1 | Q → K in ARSEGS; reduced affinity for L-tyrosine. | VAR_014031 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 494 | 1 | T → M in ARSEGS; parkinsonian symptoms in infancy. Corresponds to variant rs45471299 [ dbSNP | Ensembl ]. | VAR_014032 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 499 | 1 | V → M. Ref.16 Corresponds to variant rs1800033 [ dbSNP | Ensembl ]. | VAR_014033 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 401 | 1 | Y → S in AAA61179. Ref.1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 401 | 1 | Y → S in CAA28908. Ref.2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 401 | 1 | Y → S in CAA68472. Ref.3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 201 – 206 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 216 – 218 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 228 – 243 | 16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 257 – 270 | 14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 274 – 277 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 282 – 292 | 11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 303 – 313 | 11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 317 – 320 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 327 – 334 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 335 – 337 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 338 – 341 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 359 – 363 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 367 – 370 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 374 – 381 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 391 – 403 | 13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 404 – 406 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 416 – 418 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 430 – 433 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 435 – 442 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 445 – 449 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 455 – 457 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 460 – 466 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 468 – 480 | 13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 485 – 491 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 492 – 495 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 496 – 500 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 503 – 510 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 514 – 526 | 13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Isolation of a novel cDNA clone for human tyrosine hydroxylase: alternative RNA splicing produces four kinds of mRNA from a single gene." Kaneda N., Kobayashi K., Ichinose H., Kishi F., Nakazawa A., Kurosawa Y., Fujita K., Nagatsu T. Biochem. Biophys. Res. Commun. 146:971-975(1987) [PubMed: 2887169] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3). |
| [2] | "A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics." Grima B., Lamouroux A., Boni C., Julien J.-F., Javoy-Agid F., Mallet J. Nature 326:707-711(1987) [PubMed: 2882428] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), ALTERNATIVE SPLICING. |
| [3] | "Isolation of a full-length cDNA clone encoding human tyrosine hydroxylase type 3." Kobayashi K., Kaneda N., Ichinose H., Kishi F., Nakazawa A., Kurosawa Y., Fujita K., Nagatsu T. Nucleic Acids Res. 15:6733-6733(1987) [PubMed: 2888085] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [4] | "Structure of the human tyrosine hydroxylase gene: alternative splicing from a single gene accounts for generation of four mRNA types." Kobayashi K., Kaneda N., Ichinose H., Kishi F., Nakazawa A., Kurosawa Y., Fujita K., Nagatsu T. J. Biochem. 103:907-912(1988) [PubMed: 2902075] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING. |
| [5] | "Human chromosome 11 DNA sequence and analysis including novel gene identification." Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G. Sakaki Y.Nature 440:497-500(2006) [PubMed: 16554811] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Brain. |
| [8] | "Analysis of the 5' region of the human tyrosine hydroxylase gene: combinatorial patterns of exon splicing generate multiple regulated tyrosine hydroxylase isoforms." le Bourdelles B., Boularand S., Boni C., Horellou P., Dumas S., Grima B., Mallet J. J. Neurochem. 50:988-991(1988) [PubMed: 2892893] [Abstract] Cited for: PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [9] | "Expression of human tyrosine hydroxylase cDNA in invertebrate cells using a baculovirus vector." Ginns E.I., Rehavi M., Martin B.M., Weller M., O'Malley K.L., Lamarca M.E., McAllister C.G., Paul S.M. J. Biol. Chem. 263:7406-7410(1988) [PubMed: 2896667] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-30. |
| [10] | "A rare novel deletion of the tyrosine hydroxylase gene in Parkinson disease." Bademci G., Edwards T.L., Torres A.L., Scott W.K., Zuchner S., Martin E.R., Vance J.M., Wang L. Hum. Mutat. 31:E1767-E1771(2010) [PubMed: 20809526] [Abstract] Cited for: POSSIBLE INVOLVEMENT IN PARKINSON DISEASE. |
| [11] | "A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome." Luedecke B., Dworniczak B., Bartholome K. Hum. Genet. 95:123-125(1995) [PubMed: 7814018] [Abstract] Cited for: VARIANT ARSEGS LYS-412. |
| [12] | "Frequent sequence variant in the human tyrosine hydroxylase gene." Luedecke B., Bartholome K. Hum. Genet. 95:716-716(1995) [PubMed: 7789962] [Abstract] Cited for: VARIANT MET-112. |
| [13] | "Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene." Knappskog P.M., Flatmark T., Mallet J., Luedecke B., Bartholome K. Hum. Mol. Genet. 4:1209-1212(1995) [PubMed: 8528210] [Abstract] Cited for: CHARACTERIZATION OF VARIANT ARSEGS LYS-412. |
| [14] | "Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene." Luedecke B., Knappskog P.M., Clayton P.T., Surtees R.A.H., Clelland J.D., Heales S.J.R., Brand M.P., Bartholome K., Flatmark T. Hum. Mol. Genet. 5:1023-1028(1996) [PubMed: 8817341] [Abstract] Cited for: CHARACTERIZATION OF VARIANT ARSEGS PRO-236. |
| [15] | "Association study of structural mutations of the tyrosine hydroxylase gene with schizophrenia and Parkinson's disease." Kunugi H., Kawada Y., Hattori M., Ueki A., Otsuka M., Nanko S. Am. J. Med. Genet. 81:131-133(1998) [PubMed: 9613851] [Abstract] Cited for: VARIANT ARSEGS PRO-236, VARIANT MET-112. |
| [16] | "Systematic search for variations in the tyrosine hydroxylase gene and their associations with schizophrenia, affective disorders, and alcoholism." Ishiguro H., Arinami T., Saito T., Akazawa S., Enomoto M., Mitushio H., Fujishiro H., Tada K., Akimoto Y., Mifune H., Shiozuka S., Hamaguchi H., Toru M., Shibuya H. Am. J. Med. Genet. 81:388-396(1998) [PubMed: 9754624] [Abstract] Cited for: VARIANT MET-499. |
| [17] | "A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-DOPA-responsive dystonia in the Dutch population." van den Heuvel L.P.W.J., Luiten B., Smeitink J.A.M., de Rijk-van Andel J.F., Hyland K., Steenbergen-Spanjers G.C.H., Janssen R.J.T., Wevers R.A. Hum. Genet. 102:644-646(1998) [PubMed: 9703425] [Abstract] Cited for: VARIANT ARSEGS HIS-233. |
| [18] | "Characterization of single-nucleotide polymorphisms in coding regions of human genes." Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., Lander E.S. Nat. Genet. 22:231-238(1999) [PubMed: 10391209] [Abstract] Cited for: VARIANT MET-112. |
| [19] | Erratum Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., Lander E.S. Nat. Genet. 23:373-373(1999) |
| [20] | "Four novel mutations in the tyrosine hydroxylase gene in patients with infantile parkinsonism." Swaans R.J.M., Rondot P., Renier W.O., Van Den Heuvel L.P.W.J., Steenbergen-Spanjers G.C.H., Wevers R.A. Ann. Hum. Genet. 64:25-31(2000) [PubMed: 11246459] [Abstract] Cited for: VARIANTS ARSEGS PRO-276; MET-314; HIS-337 AND MET-494. |
| + | Additional computationally mapped references. |
Web resources
| GeneReviews |
| Wikipedia Tyrosine hydroxylase entry |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M17589 mRNA. Translation: AAA61179.1. X05290 mRNA. Translation: CAA28908.1. Y00414 mRNA. Translation: CAA68472.1. AC132217 Genomic DNA. No translation available. M24791, M24787, M24789 Genomic DNA. Translation: AAA61173.1. CH471158 Genomic DNA. Translation: EAX02493.1. BC143611 mRNA. Translation: AAI43612.1. M24791, M24787 Genomic DNA. Translation: AAA61170.1. M20911 mRNA. Translation: AAA61167.1. | ||||||||||||
| IPI | IPI00010178. IPI00218275. IPI00398179. IPI00922082. | ||||||||||||
| PIR | WHHUY4. A30002. | ||||||||||||
| RefSeq | NP_000351.2. NM_000360.3. NP_954986.2. NM_199292.2. NP_954987.2. NM_199293.2. | ||||||||||||
| UniGene | Hs.435609. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P07101. | ||||||||||||
| SMR | P07101. Positions 104-528. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| STRING | P07101. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P07101. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 239938945. | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | P07101. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000381178; ENSP00000370571; ENSG00000180176. | ||||||||||||
| GeneID | 7054. | ||||||||||||
| KEGG | hsa:7054. | ||||||||||||
| UCSC | uc001lvp.1. human. uc001lvq.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 7054. | ||||||||||||
| GeneCards | GC11M002185. | ||||||||||||
| HGNC | HGNC:11782. TH. | ||||||||||||
| HPA | CAB002522. | ||||||||||||
| MIM | 191290. gene. 605407. phenotype. | ||||||||||||
| neXtProt | NX_P07101. | ||||||||||||
| Orphanet | 101150. Autosomal recessive dopa-responsive dystonia. | ||||||||||||
| PharmGKB | PA351. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOGENOM | HBG484724. | ||||||||||||
| HOVERGEN | HBG006841. | ||||||||||||
| InParanoid | P07101. | ||||||||||||
| OMA | PKVPWFP. | ||||||||||||
| PhylomeDB | P07101. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Pathway_Interaction_DB | alphasynuclein_pathway. Alpha-synuclein signaling. p38_mk2pathway. p38 signaling mediated by MAPKAP kinases. | ||||||||||||
| Reactome | REACT_111217. Metabolism. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P07101. | ||||||||||||
| Bgee | P07101. | ||||||||||||
| CleanEx | HS_TH. | ||||||||||||
| Genevestigator | P07101. | ||||||||||||
| GermOnline | ENSG00000180176. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR001273. ArAA_hydroxylase. IPR018301. ArAA_hydroxylase_Fe/CU_BS. IPR019774. Aromatic-AA_hydroxylase_C. IPR005962. Tyr_3_mOase. IPR019773. Tyrosine_3-monooxygenase-like. IPR021164. Tyrosine_hydroxylase_CS. [Graphical view] | ||||||||||||
| Gene3D | G3DSA:1.10.800.10. Aaa_hydroxylase. 1 hit. | ||||||||||||
| KO | K00501. | ||||||||||||
| PANTHER | PTHR11473. Aaa_hydroxylase. 1 hit. | ||||||||||||
| Pfam | PF00351. Biopterin_H. 1 hit. PF12549. TOH_N. 3 hits. [Graphical view] | ||||||||||||
| PIRSF | PIRSF000336. TH. 1 hit. | ||||||||||||
| PRINTS | PR00372. FYWHYDRXLASE. | ||||||||||||
| SUPFAM | SSF56534. Aaa_hydroxylase. 1 hit. | ||||||||||||
| TIGRFAMs | TIGR01269. Tyr_3_monoox. 1 hit. | ||||||||||||
| PROSITE | PS00367. BH4_AAA_HYDROXYL_1. 1 hit. PS51410. BH4_AAA_HYDROXYL_2. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| DrugBank | DB00120. L-Phenylalanine. DB00135. L-Tyrosine. DB00765. Metyrosine. DB00360. Tetrahydrobiopterin. | ||||||||||||
| NextBio | 27583. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | TY3H_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P07101 Secondary accession number(s): B7ZL70 Q15589 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 11 Human chromosome 11: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with